Clinical Update
New Combination Therapies
David Liebers, MD. Research Assistant Professor of Psychiatry, NYU Langone, Department of Psychiatry.
Dr. Liebers reports he is the principal investigator for Autobahn Therapeutics. Relevant financial relationships listed for the author have been mitigated. Dr. Aiken has reviewed this educational activity and has determined that there is no commercial bias as a result of this financial relationship.


_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.webp?t=1729528747)



